Dr David Bennett, former head of NHS Foundation Trust regulator Monitor, has been appointed the new Chair of Viapath, the pathology joint venture owned by Guy’s and St Thomas’, King’s College Hospital and Serco.
David Bennett moves to Viapath
Since its inception in 2009, Viapath has been a UK provider of pathology services to the NHS and private healthcare market. It employs 1300 scientists and other employees and provides one of the widest test repertoires in the NHS.